MedPath

Smartphone Application for Smoking Cessation

Not Applicable
Completed
Conditions
Smoking
Interventions
Behavioral: Experimental App
Behavioral: Active Comparator App
Registration Number
NCT02134509
Lead Sponsor
Yale University
Brief Summary

The purpose of this study is to test the effectiveness of a smartphone application for smoking cessation in smokers ages 18 to 65 years.

Detailed Description

In this randomized control trial, subjects will be randomly assigned to receive one of two treatments: (1) a standard smartphone application to support smokers working to become quit-free, or (2) the tested intervention, an app that trains behavioral strategies for smoking cessation. The primary endpoint of interest will be 1-week point prevalence abstinence at end of treatment, and at 3 and 6 months follow-up for individuals.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
511
Inclusion Criteria
  • Smoke 5+ cigarettes/day
  • < 3 months abstinence in the past year
  • Have a smartphone
  • Score greater than or equal to 8 of 10 on the Contemplation Ladder (Biener & Abrams, 1991)
Read More
Exclusion Criteria
  • None
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental AppExperimental AppThis is a 3-week smartphone-based training program that trains behavioral strategies for smoking cessation by helping smokers self-monitor their smoking habits, recognize when and how often they smoke, identify triggers for smoking, and learn methods to become more mindful of triggers, to quit smoking with a target quit date of 3 weeks.
Active comparator appActive Comparator AppThis is a 3-week smartphone application for smoking cessation in which smokers self-monitor their smoking habits, mood, and experience, to quit smoking with a target quit date of 3 weeks.
Primary Outcome Measures
NameTimeMethod
Point prevalence abstinence at 6 months6 months after beginning treatment

Subjects will be assessed for smoking abstinence at a 6-month follow-up.

Secondary Outcome Measures
NameTimeMethod
Point prevalence abstinence at 3 months3 months after beginning treatment

Subjects will be assessed for smoking abstinence at a 3-month follow-up.

Trial Locations

Locations (1)

Yale University School of Medicine

🇺🇸

New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath